102 results
Page 4 of 6
424B3
88o0xvpdg4jkvhjp
13 Oct 20
Prospectus supplement
9:42am
F-1/A
8sahe83 mi8unmdc5ke
9 Oct 20
Registration statement (foreign) (amended)
12:00am
6-K
EX-99.1
skbb1giy jsa
9 Oct 20
Interim Consolidated Financial Statements
12:00am
F-1/A
EX-1.1
w5wyjxntx 1uy802h93
9 Oct 20
Registration statement (foreign) (amended)
12:00am
6-K
EX-99.2
087yhylba3
9 Oct 20
Interim Consolidated Financial Statements
12:00am
6-K
fb1su5sjwy7gf60mjbir
16 Sep 20
Developing cannabinoid based pharmaceuticals Corporate Presentation • September 2020
7:11am
6-K
EX-99.1
nk5jhc3btderyrxn
16 Sep 20
Developing cannabinoid based pharmaceuticals Corporate Presentation • September 2020
7:11am
F-1
m6vib1ws82z8ercf
8 Sep 20
Registration statement (foreign)
5:31pm
6-K
EX-99.1
mryr139k1 hp2vks
9 Jul 20
Therapix Biosciences Announces OTC Pink Ticker Symbol 'TRPXY' and Removal of Injunction by Israeli Court
5:02pm
6-K
EX-99.3
715umet9l j0
1 Jul 20
Report of Foreign Private Issuer
9:05am
6-K
oaikepsedpp8k
19 May 20
Share Transfer Agreement
5:18pm
6-K
acgqgw
30 Apr 20
Current report (foreign)
4:26pm
6-K
EX-99.1
12jypf
28 Apr 20
Current report (foreign)
8:37am
6-K
EX-99.2
t3j4ejm fij
22 Apr 20
Therapix Biosciences Announces Appointment of New CEO
5:30pm
424B4
ml5o1g9j6 79f
2 Apr 20
Prospectus supplement with pricing info
5:28pm
F-1/A
EX-4.7
kemuo52 9ws
31 Mar 20
Registration statement (foreign) (amended)
11:31am
F-1/A
wvp lv491bne5czd7
31 Mar 20
Registration statement (foreign) (amended)
11:31am